Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Watch the Recording What Youll Learn Shifts in payer perspectives on obesity as a lifestyle condition versus a chronic medical condition Payers GLP-1 coverage decisions and management strategies Updates on affordability concerns and price willing to pay for GLP-1s for obesity The influence of discontinuation rates on obesity GLP-1 coverage conversations The role of weight management vendor partnerships as part of obesity GLP-1 coverage strategies Payers preparedness for expanded GLP-1 indications and new medications entering the market Attendees will gain actionable strategies and insights to optimize their pharmacy benefit design for these high-impact medications in 2026 and beyond
Store at room temperature
Time to slam 15 milligrams of melatonin and go comatose
H., Aljameeli, A
